(Rac) -Sograzepide
(Rac) -Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.
Product Specifications
CAS Number
168161-71-5
Product Name Alternative
(Rac) -Netazepide; (Rac) -YF 476; (Rac) -YM-220
UNSPSC
12352005
Target
Cholecystokinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rac-sograzepide.html
Purity
98.98
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(NC)=C1)NC2C(N(CC(C(C)(C)C)=O)C3=CC=CC=C3C(C4=NC=CC=C4)=N2)=O
Molecular Formula
C28H30N6O3
Molecular Weight
498.58
References & Citations
[1]Hamish Ryder, et al. Benzodiazepin derivatives useful as cck-receptor antagonists. WO 1993016999 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCKBR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680906-100 1x 100 µL
Cytokeratin 7 (KRT7/760 + KRT7/903), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402551-100 1x 100 µL
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (rNGFR/1965), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
